@kBiggs I&#39;d wear a $MRK uniform
$DCTH Bet we get bought out by $MRK
$MRK $DCTH ðŸš€
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
$MRK hmmâ€¦ do not follow this acct to trade
$MRK Bought this a few years ago after an earnings miss. Been reinvesting all dividends. Long MRK
$MRK 65 Calls BUYING Activity expiring on 18th Aug, Vol 1554
$MRK 64 Calls BUYING Activity expiring on 21st Jul, Vol 2499
$MRK 63 Calls BUYING Activity expiring on 21st Jul, Vol 1001
$MRK key stats, financial summary and business profile https://stockrow.com/MRK
$MRK 60 Puts SELLING Activity expiring on 21st Jul, Vol 2515
$MRK lotto calls made 3x on my XLE last night. Buying Friday&#39;s $64 for .07 @CaballoBlanco @superbigdaddy we all know IBB going to roar!
$MRK heat
$MRK 63.5 Calls BUYING Activity expiring on 21st Jul, Vol 1240
$AUPH not getting acquired this week by $MRK....getting acquired every week by smart longs....rumor has it.
$MRK easy bounce play here!
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
Report Sees Adult Vaccines Market Reaching $20B by 2022 - $GSK, $MRK, $SNY, $PFE http://crweworld.com/newsroom/prnewswire?rkey=20170711IO38827&amp;filter=10284
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
3 Dividend Stocks in Healthcare http://bit.ly/110717AMGN $AMGN $CHRS $AZN $MDT $MRK $MBY
$DVAX Is likely to be bought by $MRK or $GSK. Assume the approval or good SD-101. If one of these happens, easily $25 to $40.
Health Care Trades In Line with Broader Market https://www.briefing.com/investor/markets/stock-market-update/2017/7/11/health-care-trades-in-line-with-broader-market.htm $IBB $PFE $MRK
Merck &amp; Company downgraded by BidaskClub to sell. http://www.marketbeat.com/r/848731 $MRK
Bydureon Auto-Injector May Boost the Drugâ€™s Sales in Future Years http://marketrealist.com/?p=2188474 $AZN $JNJ $LLY $MRK $VT
Farxiga Could See Robust Demand in International Markets in 2017 http://marketrealist.com/?p=2188432 $AZN $JNJ $LLY $MRK $PPH
7/11 200D MA Watch List: $XME $MRK $IYR $BUD $ETE $WY $AIG $AMGN $POT $NUE $ALXN $LULU $ULTA $EPD $HST $PG $UPS $PAY $FOXA $TLT
How Celgene Stock Performed in 2Q17 http://marketrealist.com/?p=2190727 $AMGN $CELG $IXJ $MRK $PFE
Farxiga Expected to Drive AstraZenecaâ€™s Performance in Diabetes Segment http://marketrealist.com/?p=2188389 $AZN $JNJ $LLY $MRK $VEU
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
Bloggers are bullish on $MRK: https://www.finstead.com/symbol/info/MRK/bloggers
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Estimize EPS expectations are 1.58% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
$ADRO Earns $2.0M milestone payment under its worldwide licensing deal with $MRK http://crweworld.com/article/news-provided-by-globenewswire/116061/aduro-announces-milestone-achieved-relating-to-collaboration-with-merckfor-development-of-anti-cd27-antibody-for-the-treatment-of-cancer
$MRK Major Pharma Short Sellers Become More Selective via https://finzine.com
Jefferies Group LLC Sets Merck &amp; Company Q2 2017 Earnings Estimates at $0.86 Per Share. $MRK http://www.marketbeat.com/x/327445
7/13 200D MA Watch List: $CF $MYL $LOW $FOXA $GRPN $LYB $DBA $CARA $MRK $LULU $AMGN $ETE $BMY $NUE $AIG $POT $CBS $SRPT $IEF $SHAK
$ADRO receives $2M milestone payment from $MRK http://bit.ly/2thVPlM
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK Lilly Settles Patent Litigation on Cialis with Generic Firms via https://finzine.com
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
Lilly Settles Patent Litigation on Cialis with Generic Firms http://bit.ly/2sU5BeI $LLY $AZN $MRK $SNY
5 Pharma &amp; Biotech Stocks That Could Be Big Winners in Q2 Earnings http://bit.ly/2umFhxW $GILD $CELG $MRK $LLY
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
5 Pharma &amp; Biotech Stocks That Could Be Big Winners in Q2 Earnings http://bit.ly/2tNaMQt $LLY $GILD $CELG $MRK $SHPG @zacks
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
$MRK analysts on Estimize are expecting -4.42% YoY EPS growth for Q2, down from -1.12% in Q1 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
600+ Companies That All Have One Positive Trait In Common http://buff.ly/2thvBQe

$MNST $MO $MOMO $MON $MPAA $MPX $MRK $MSB $MSFT $MSGN
$MRK to meet w/ $DCTH on Monday, July 17 in NYC?

Fun fact: Apparently Merck has former Delcath employees on staff.
Estimize revenue expectations are 0.19% higher than that of Wall Street for $MRK Q2 [Reporting 07/28 BMO]
http://www.estimize.com/intro/mrk?utm_content=MRK&amp;amp;utm_medium=eps_update&amp;amp;utm_source=stocktwits#chart=historical
The Top Dogs In The Market&#39;s Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
